Mariken B. de Koning

527 total citations
21 papers, 322 citations indexed

About

Mariken B. de Koning is a scholar working on Psychiatry and Mental health, General Health Professions and Clinical Psychology. According to data from OpenAlex, Mariken B. de Koning has authored 21 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 6 papers in General Health Professions and 5 papers in Clinical Psychology. Recurrent topics in Mariken B. de Koning's work include Schizophrenia research and treatment (11 papers), Mental Health and Patient Involvement (6 papers) and Functional Brain Connectivity Studies (4 papers). Mariken B. de Koning is often cited by papers focused on Schizophrenia research and treatment (11 papers), Mental Health and Patient Involvement (6 papers) and Functional Brain Connectivity Studies (4 papers). Mariken B. de Koning collaborates with scholars based in Netherlands, United Kingdom and Germany. Mariken B. de Koning's co-authors include Oswald Bloemen, Thérèse van Amelsvoort, Don Linszen, Lieuwe de Haan, Dorien H. Nieman, Hiske E. Becker, Peter Dingemans, Nicole Schmitz, Jan Booij and Mark van der Gaag and has published in prestigious journals such as SHILAP Revista de lepidopterología, Psychological Medicine and Psychopharmacology.

In The Last Decade

Mariken B. de Koning

17 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mariken B. de Koning Netherlands 9 171 123 103 53 36 21 322
Amanda F. Moates United States 7 269 1.6× 189 1.5× 63 0.6× 38 0.7× 33 0.9× 7 403
Cassandra Wannan Australia 11 193 1.1× 188 1.5× 90 0.9× 14 0.3× 34 0.9× 28 375
Jeffrey Lieberman United States 9 170 1.0× 107 0.9× 118 1.1× 64 1.2× 20 0.6× 21 432
Jesse G. Brand United States 8 155 0.9× 138 1.1× 111 1.1× 25 0.5× 17 0.5× 10 359
Paul Rivkin United States 5 236 1.4× 194 1.6× 61 0.6× 21 0.4× 19 0.5× 6 392
P. Brazo France 10 207 1.2× 142 1.2× 54 0.5× 20 0.4× 58 1.6× 26 362
Gian Marco Giobbio Italy 13 269 1.6× 215 1.7× 159 1.5× 25 0.5× 37 1.0× 18 451
Lorna Donnelly United Kingdom 3 202 1.2× 123 1.0× 88 0.9× 9 0.2× 26 0.7× 6 269
Leigh Townsend United Kingdom 7 142 0.8× 62 0.5× 39 0.4× 36 0.7× 48 1.3× 10 401
Heike Anderson‐Schmidt Germany 9 129 0.8× 100 0.8× 66 0.6× 14 0.3× 27 0.8× 18 241

Countries citing papers authored by Mariken B. de Koning

Since Specialization
Citations

This map shows the geographic impact of Mariken B. de Koning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariken B. de Koning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariken B. de Koning more than expected).

Fields of papers citing papers by Mariken B. de Koning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariken B. de Koning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariken B. de Koning. The network helps show where Mariken B. de Koning may publish in the future.

Co-authorship network of co-authors of Mariken B. de Koning

This figure shows the co-authorship network connecting the top 25 collaborators of Mariken B. de Koning. A scholar is included among the top collaborators of Mariken B. de Koning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariken B. de Koning. Mariken B. de Koning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Koning, Mariken B. de, Inez Myin‐Germeys, Frederike Schirmbeck, et al.. (2025). Investigating the impact of acceptance and commitment therapy for mental healthcare professionals: the effect on patients´ self-stigmatization, a pilot study. PubMed. 15. 1390949–1390949.
3.
Schirmbeck, Frederike, Astrid Vellinga, Martijn Kikkert, et al.. (2024). Perspective matters in recovery: the views of persons with severe mental illness, family and mental health professionals on collaboration during recovery, a qualitative study. BMC Psychiatry. 24(1). 802–802. 2 indexed citations
4.
5.
Haan, Lieuwe de, et al.. (2024). Paralytic ileus in a patient on clozapine therapy showing an inverted clozapine/norclozapine ratio after switching valproic acid to carbamazepine: a case report. SHILAP Revista de lepidopterología. 14. 1957172799–1957172799. 1 indexed citations
6.
Vellinga, Astrid, Mariken B. de Koning, Frederike Schirmbeck, et al.. (2024). The Association Between Change in Symptom Severity and Personal Recovery in Patients With Severe Mental Illness. The Journal of Nervous and Mental Disease. 213(1). 1–6.
7.
8.
9.
Koning, Mariken B. de, et al.. (2021). [The underrepresentation of complex patient groups in scientific research: ethical considerations].. Tijdschrift voor psychiatrie. 63(10). 731–736. 1 indexed citations
10.
Schirmbeck, Frederike, Jentien M. Vermeulen, Piotr J. Quee, et al.. (2020). Association between cognitive phenotype in unaffected siblings and prospective 3- and 6-year clinical outcome in their proband affected by psychosis. Psychological Medicine. 51(11). 1916–1926. 1 indexed citations
11.
Vellinga, Astrid, Mariken B. de Koning, Frederike Schirmbeck, et al.. (2018). The impact of affective symptoms on personal recovery of patients with severe mental illness. International Journal of Social Psychiatry. 64(6). 521–527. 12 indexed citations
12.
Vingerhoets, Claudia, Oswald Bloemen, Erik Boot, et al.. (2017). Dopamine in high-risk populations: A comparison of subjects with 22q11.2 deletion syndrome and subjects at ultra high-risk for psychosis. Psychiatry Research Neuroimaging. 272. 65–70. 8 indexed citations
13.
Kikkert, Martijn, Jan Theunissen, Mariken B. de Koning, et al.. (2016). Homesick: residential and care patterns in patients with severe mental illness. BMC Psychiatry. 16(1). 431–431. 7 indexed citations
14.
Bakker, Geor, Matthan W.A. Caan, Renée S. Schluter, et al.. (2016). Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosis. Psychological Medicine. 46(11). 2299–2311. 20 indexed citations
15.
Koning, Mariken B. de, Erik Boot, Oswald Bloemen, et al.. (2015). PRODH rs450046 and proline x COMT Val158Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome. Psychopharmacology. 232(17). 3111–3122. 12 indexed citations
16.
Koning, Mariken B. de, Oswald Bloemen, Jan Booij, et al.. (2014). Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis. Journal of Psychopharmacology. 28(6). 553–560. 23 indexed citations
17.
Bloemen, Oswald, Mariken B. de Koning, Tobias Gleich, et al.. (2012). Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis. European Neuropsychopharmacology. 23(2). 126–132. 30 indexed citations
18.
Koning, Mariken B. de, Erik Boot, Oswald Bloemen, et al.. (2012). Startle reactivity and prepulse inhibition of the acoustic startle response are modulated by catechol-O-methyl-transferase Val158 Met polymorphism in adults with 22q11 deletion syndrome. Journal of Psychopharmacology. 26(12). 1548–1560. 15 indexed citations
19.
Koning, Mariken B. de, Oswald Bloemen, Thérèse van Amelsvoort, et al.. (2009). Early intervention in patients at ultra high risk of psychosis: benefits and risks. Acta Psychiatrica Scandinavica. 119(6). 426–442. 60 indexed citations
20.
Bloemen, Oswald, Mariken B. de Koning, Nicole Schmitz, et al.. (2009). White-matter markers for psychosis in a prospective ultra-high-risk cohort. Psychological Medicine. 40(8). 1297–1304. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amanda F. Moates Breakdown of academic impact, for papers by Cassandra Wannan Breakdown of academic impact, for papers by Jeffrey Lieberman Breakdown of academic impact, for papers by Jesse G. Brand Breakdown of academic impact, for papers by Paul Rivkin Breakdown of academic impact, for papers by P. Brazo Breakdown of academic impact, for papers by Gian Marco Giobbio Breakdown of academic impact, for papers by Lorna Donnelly Breakdown of academic impact, for papers by Leigh Townsend Breakdown of academic impact, for papers by Heike Anderson‐Schmidt
Rankless by CCL
2026